News

This year, we highlight three emerging professionals who played key roles in the speed of the development of the COVID-19 vaccine during the pandemic.

This White Paper on "Comparability for Cell and Gene Therapy Products" will provide you with an overview from CGTP Summit 2023.

CASSS thanks four former Board Members who served in 2023 that are no longer serving in 2024.

CASSS has honored Wassim Nashabeh, PhD with its prestigious Hancock Award for Outstanding Achievement in CMC Regulatory Science.

CASSS is excited to announce thirty-four new Associate Directors (ADs) will be joining the CASSS leadership.

CASSS is excited to announce the election of Christof Finkler, Nomalie Jaya, Andy Weiskopf, and Heidi Zhang to the Board of Directors.

The Member Spotlight is an ongoing Q&A series focused on getting to know the CASSS community. Today’s spotlight shines on James Carroll, Sr. Director at Pfizer, Inc.

It’s that time – the calendar shows that it is late December, when typically, we review the year behind us and look forward to the year ahead of us.

CASSS is pleased to announce that Jamie Moore and Mark Schenerman have been elected President and Vice President, respectively, to the CASSS Board of Directors.

CASSS is excited to announce the winners of the 2024 WCBP Emerging Leader Award in the Advancement of Scientific Knowledge (ELAA).